The QT Ultrasound Breast Scanner - 1 is for use as an ultrasonic imaging system to provide reflection-mode and transmission-mode images of a patient's breast. The device is not intended to be used as a replacement for screening mammography.

Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Small Organ (Breast) - Reflection, Transmission (Speed of Sound). QT Ultrasound Breast Scanner-1 is intended for ultrasonic breast exams.

Device Description

The QT Ultrasound Breast Scanner - 1 is an automated software-controlled ultrasonic imaging system that performs a standardized scan of the whole breast. The OT Ultrasound Breast Scanner - 1 is comprised of a Patient Scanning System, Operator Console and Viewer Console.

The Patient Scanning System consists of a patient support table, scan tank, water management system, ultrasound transducer arrays and all associated image processing electronics. The scan tank is centered below a patient's breast and contains the ultrasound transducer arrays. The transducer arrays include a set of three reflection transducers that transmit pulsed ultrasound plane waves into targeted tissues using the water bath in the scan tank as a coupling medium. An additional transmitter and receiver array pair collect the ultrasound energy to provide speed of sound values.

During scanning, a patient lies prone on the examination table with the breast suspended in a warm water bath maintained near skin temperature. Images are automatically acquired on a pendant breast positioned with the nipple as a point of reference. The transducer arrays rotate about a vertical axis to circle the breast in the coronal plane. The array is then translated vertically, and the scanning process is repeated until the entire breast is scanned, allowing B-scan images to be constructively combined into tomographic, speed of sound and reflection ultrasound images.

The QT Ultrasound Breast Scanner – 1 outputs the images to the QTviewer™ which allows the images to be stored until they are reviewed on a Viewer Console. Coronal, axial and sagittal images are generated for review by the radiologist. Speed of sound images may be queried by the Probe and Region of Interest (ROI) tools provided in the Viewer Console. These tools provide speed of sound values in meters/sec. to aid in diagnostic evaluation of the breast.

AI/ML Overview

This document describes a Special 510(k) submission (K182213) for a modified QT Ultrasound Breast Scanner - 1. The key takeaway is that no clinical study was performed or required for this specific submission because the device is a modification of a previously cleared device (K162372) and the modifications are limited to software updates (QTviewer Software Module). The manufacturer asserts that these software changes do not raise new questions of safety or effectiveness. Therefore, the response will reflect the absence of clinical performance data for this particular submission.

Here's the breakdown based on your requested information, acknowledging the limitations due to the nature of this 510(k) submission:

1. A table of acceptance criteria and the reported device performance

Since this is a Special 510(k) for software modifications and does not involve a clinical performance study, there are no specific clinical acceptance criteria or reported device performance in terms of clinical accuracy or effectiveness. The acceptance criteria for this submission were primarily focused on demonstrating that the software modifications did not adversely affect the safety or effectiveness of the previously cleared device, and that the device still meets its design specifications.

Acceptance Criteria Category	Reported Device Performance (for software modifications)
Software Functionality	All requirements for the modified QTviewer Software Module were met, ensuring it performed as designed.
Usability	A small usability investigation demonstrated the new user interface (Research Mode) meets user requirements.
No New Safety/Effectiveness Issues	Verification and validation testing confirmed that modifications do not raise new or different questions of safety and effectiveness compared to the predicate device.
Design Specifications	The modified device successfully meets design specifications.

2. Sample sized used for the test set and the data provenance

Test Set Sample Size: Not applicable. No clinical test set with patient data was used for this Special 510(k) submission as it focuses on software modifications and non-clinical testing.
Data Provenance: Not applicable. The testing primarily involved internal software verification and validation, and usability testing, not patient data.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

Not applicable. As no clinical test set with patient data was used, no experts were needed to establish ground truth in a clinical context. Usability testing involved users, but not "experts" establishing ground truth in the clinical sense.

4. Adjudication method for the test set

Not applicable. There was no clinical test set requiring adjudication.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

No. An MRMC comparative effectiveness study was not performed. This submission is for a modified ultrasound scanner, and the modifications are software updates to the viewing module, not the introduction of AI for interpretation assistance.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not applicable. This device is an imaging system, not an AI algorithm for standalone interpretation. The modifications are to the viewing software.

7. The type of ground truth used

For the software verification and validation, the "ground truth" was the defined software requirements and design specifications. For the usability testing, the ground truth was user requirements. No clinical ground truth (e.g., pathology, outcomes data) was used or required for this specific submission as no clinical performance was being evaluated.

8. The sample size for the training set

Not applicable. As this submission describes modifications to existing viewing software and not a new machine learning algorithm, there was no "training set" in the context of AI/ML development.

9. How the ground truth for the training set was established

Not applicable. See point 8.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

September 14, 2018

QT Ultrasound LLC Mark W. Lenox Chief Technology Officer 3 Hamilton Landing. Suite 160 NOVATO, CA 94949

Re: K182213

Trade/Device Name: OT Ultrasound Breast Scanner - 1 Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: Class II Product Code: IYO, ITX Dated: August 14, 2018 Received: August 15, 2018

Dear Mark Lenox:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice

(https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Digitally signed by Jeffre
-S
DN: c=US, o=U.S. Govern
ou=HHS, ou=FDA, ou=Pe
0.9.2342.19200300.100.1
9725, cn=Jeffrey J. Ballym
Date: 2018.09.14 13:52:5

c=US, o=U.S. Government,
=HHS, ou=FDA, ou=People,
2342.19200300.100.1.1=200056
5, cn=Jeffrey J. Ballyns -S
e: 2018.09.14 13:52:52 -04'00'

for Robert A. Ochs. Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K182213

Device Name QT Ultrasound Breast Scanner - 1

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)
-------------------------------------------------

For Evaluation Use (Per 21 CFR 201.66, Subpart D)
For Compassionate Use (21 CFR 312.300)

X | Prescription Use (Part 21 CFR 801 Subpart D)

| | Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Diagnostic Ultrasound Indications for Use

System: QT Ultrasound Breast Scanner-1

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application		Mode of Operation
General(Track 1 only)	Specific (Tracks 1 & 3)	B	M	PWD	CWD	ColorDoppler	Combined	Other
Ophthalmic	Ophthalmic
	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ (Breast)	N1						N2
	Neonatal Cephalic
Fetal Imaging& Other	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Intravascular
	Other (Specify)
	Cardiac Adult
	Cardiac Pediatric
Cardiac	Intravascular (Cardiac)
	Trans-esoph. (Cardiac)
	Intra-cardiac
	Other (Specify)
Peripheral	Peripheral vessel
Vessel	Other (Specify)

N=New Indication; P = previously cleared by FDA; E = added under this appendix

1 – Reflection

2 – Transmission (Speed of Sound)

Additional Comments: QT Ultrasound Breast Scanner-1 is intended for ultrasonic breast exams

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows the logo for QT Ultrasound. The logo features the letters "QT" in a light green color, with the word "ultrasound" in a light gray color next to it. The font is sans-serif and modern.

510(K) SUMMARY

In accordance with 21 CFR 807.92 the following summary of information is provided:

1.0 SUBMITTER INFORMATION

Submitted By	QT Ultrasound® LLC3 Hamilton Landing, Suite 160Novato, CA 94949
Contact Information	Mark W. Lenox, PhDPhone: (865) 382-2649Fax: (415) 234-6511Email: mark.lenox@qtultrasound.com
Date of Submission	September 12, 2018
Type of Submission	Special 510(k)Modification to QT Ultrasound Breast Scanner – 1(K162372)
DEVICE INFORMATION
Trade / Proprietary Name	QT Ultrasound Breast Scanner – 1
Common Name	System, Imaging, Pulsed Echo UltrasonicTransducer, Ultrasonic, Diagnostic
Classification Name andRegulation Number	21CFR §892.1560 Ultrasonic pulsed echo imaging system21CFR §892.1570 Diagnostic ultrasonic transducer

Product Codes IYO, ITX

3.0 PREDICATE DEVICE

2.0

The predicate device is the QT Ultrasound Breast Scanner - 1, also manufactured by QT Ultrasound, LLC. QT Ultrasound Breast Scanner - 1 received market clearance under 510(k) number K162372.

{5}------------------------------------------------

Image /page/5/Picture/0 description: The image shows the logo for QT Ultrasound. The logo consists of the letters "QT" in a light green color, with the word "ultrasound" in a light gray color next to it. The font is sans-serif and the overall design is simple and modern.

4.0 DEVICE DESCRIPTION

INTENDED USE 5.0

The OT Ultrasound Breast Scanner - 1 is for use as an ultrasonic imaging system to provide reflection-mode and transmission-mode images of a patient's breast. The device is not intended to be used as a replacement for screening mammography.

6.0 PREDICATE DEVICE COMPARISON

The modified QT Ultrasound Breast Scanner - 1 is substantially equivalent to the predicate device, the OT Ultrasound Breast Scanner - 1 cleared by the FDA in K162372. QT Ultrasound claims substantial equivalence because the proposed device has an equivalent intended use, operating principles, fundamental scientific technology, technological characteristics, and physical and operational specifications as compared to

{6}------------------------------------------------

Image /page/6/Picture/0 description: The image shows the logo for QT ultrasound. The logo consists of the letters "QT" in a light green color, followed by the word "ultrasound" in a light gray color. The logo is simple and modern, and it is likely used to represent a medical imaging company or service.

the predicate device. The modified QT Ultrasound Breast Scanner - 1 and the predicate device utilize B-mode grayscale ultrasound images to achieve their intended use. Both the modified QT Ultrasound Breast Scanner - 1 and the predicate device are table-top systems that have automatic scanning transducers to image breast tissue.

A brief summary of the similarities and differences between the modified QT Ultrasound Breast Scanner – 1 and the QT Ultrasound Breast Scanner – 1 (K162372) is included below:

Similarities

The fundament scientific technology and all Technological Characteristics are the same for both the modified QT Ultrasound Breast Scanner – 1 and the QT Ultrasound Breast Scanner - 1 (K162372); all technological characteristics and are listed below:

Both systems use an automated transducer to acquire images of a patient's breast. ●
o Both systems use broadband transducers.
Both systems acquire and process B-mode grayscale images of a patient's breast.
Both systems acquire and process grayscale speed of sound images of a patient's breast.
. Both systems position the patient in a prone position lying on their examination table with the patient's breast in a pendulous position within an imaging chamber.
Both systems position the patient's breast in a fluid environment to eliminate the need for breast compression and to facilitate the transmission of ultrasound waves.
. Both systems display of speed of sound Information is the same. Both provide grayscale speed of sound images that may be acquired by Probe and/or ROI tools available in the OTviewer. Both systems use this information as an aid/reference information for diagnostic evaluation of the breast.
. Both systems display 3-D volume image acquisition.
. Both systems perform image reconstruction in 3-D.

Differences

The differences between the modified QT Ultrasound Breast Scanner - 1 and the QT Ultrasound Breast Scanner – 1 (K162372) are the modifications made to the QTviewer Software Module. The summary of the differences between the modified QT Ultrasound Breast Scanner - 1 and the QT Ultrasound Breast Scanner - 1 (K162372) are listed in Table 2-1.

{7}------------------------------------------------

Table 2-1. Differences Between the Modified QT Ultrasound Breast Scanner – 1 and theQT Ultrasound Breast Scanner – 1 (K162372)
Modification	Discussion
ModifiedQTviewerSoftware Module	Various bug fixes, cosmetic changes, addition of annotation features,snapshot feature and research mode, along with enhancements were madeto the QTviewer Software Module that was part of the FDA cleared QTUltrasound Breast Scanner – 1 (K162372).

The differences noted between the modified QT Ultrasound Breast Scanner - 1 and the predicate device, the QT Ultrasound Breast Scanner - 1 (K162372), do not present any new or different questions related to safety and effectiveness.

7.0 SUMMARY OF NON-CLINICAL TESTING

The function and performance of the modified OT Ultrasound Breast Scanner - 1 has been evaluated through non-clinical design verification and validation testing. All necessary testing was conducted on the proposed QT Ultrasound Breast Scanner - 1 to support a determination of substantial equivalence to the unmodified predicate device. Specifically, the impacts of the design changes presented with the subject device were evaluated through Design Control, and a number of required testing accordingly determined and subsequently performed. Testing included system performance and simulated use tests. When applicable, non-clinical testing was conducted per the standards listed in Table 2-2. All necessary validation testing, including comprehensive software verification and validation, was performed, the results of which demonstrate that the modified QT Ultrasound Brast Scanner - 1 successfully meets design specification. As a part of design validation, a small usability investigation was conducted, which demonstrated the new user interface presented with Reseach Mode meets user requirements.

This testing confirms that the design changes presented with the subject device do not raise new questions of safety and effectivess, the subject device meets design specifications, and that the subject and predicate devices are substantially equivalent. The modified QT Ultrasound Breast Scanner – 1 is only different due to an updated version of the QTviewer Software Module; therefore, not all testing was applicable since the original submission. A comparsion of all testing between the modified OT Ultrasound Breast Scanner - 1 and the predicate, QT Ultrasound Breast Scanner - 1 (K162372) is shown in Table 2-2.

{8}------------------------------------------------

Image /page/8/Picture/0 description: The image contains the text "QT ultrasound". The letters "QT" are larger and in a light green color, while the word "ultrasound" is in a smaller, light gray font. The text appears to be a logo or branding element.

Table 2-2. Testing Performed
Type of Testing	Tests Performed	QT UltrasoundBreast Scanner – 1(K162372)	Modified QTUltrasound BreastScanner – 1(This submission)
Electrical SafetyAAMI ES60601-1:2005/(R)2012 AndA1:2012 Medicalelectrical equipment -Part 1: Generalrequirements for basicsafety and essentialperformance	All applicable electrical,basic safety andessential performancetests.Testing was conductedby Intertek, anindependent testinglaboratory, located inMenlo Park, CA.	Performed	Not Applicable; theonly modificationmade to the QTUltrasound BreastScanner – 1 is anupdated QTviewerSoftware Module.
ElectromagneticCompatibilityIEC 60601-1-2 Edition3: 2007-03 Medicalelectrical equipment -Part 1-2: Generalrequirements for basicsafety and essentialperformance - CollateralStandard:Electromagneticdisturbances -Requirements and tests	All applicable testingpertaining toelectromagneticcompatibility.Testing was conductedby Intertek, anindependent testinglaboratory, located inMenlo Park, CA.	Performed	Not Applicable; theonly modificationmade to the QTUltrasound BreastScanner – 1 is anupdated QTviewerSoftware Module.
UsabilityIEC 62366 Edition 1.12014-01 - Medicaldevices- Application ofusability engineering tomedical devicesIEC 60601-1-6 Edition3.1 2013-10 - Medicalelectrical equipment Part1-6 Generalrequirements for safety -Collateral Standard:Usability	All applicable testingpertaining to usability.Testing was conductedby Intertek, anindependent testinglaboratory, located inMenlo Park, CA.	Performed	Performed
Table 2-2. Testing Performed
Type of Testing	Tests Performed	QT UltrasoundBreast Scanner – 1(K162372)	Modified QTUltrasound BreastScanner – 1(This submission)
Acoustic OutputIEC 60601-2-37 Edition2.0 2007 Medicalelectrical equipment –Part 2-37: Particularrequirements for thebasic safety andessential performance ofultrasonic medicaldiagnostic andmonitoring equipment.NEMA UD 2-2004(R2009) AcousticOutput MeasurementStandard for DiagnosticUltrasound Equipment –Revision 3	All applicable testingpertaining to therequirements for thesafety of ultrasonicmedical diagnostic andmonitoring equipmentand to demonstratecompliance with the"Acoustic OutputMeasurement Standardfor DiagnosticUltrasound Equipment".Testing was conductedby QT Ultrasound andwitnessed by Intertek,an independent testinglaboratory, located inMenlo Park, CA. TheQT Ultrasound BreastScanner – 1 meets allTrack 1 acoustic outputrequirements. Theresults of acousticoutput testing are listedin Table 2-3 below.	Performed	Not Applicable; theonly modificationmade to the QTUltrasound BreastScanner – 1 is anupdated QTviewerSoftware Module.
Software DevelopmentIEC 62304:2006 (FirstEdition) – Medicaldevice software –Software life cycleprocesses	Internal procedures forsoftware life cyclemanagement were usedfor softwaredevelopment,verification / validationand configurationcontrol	Performed	Not Applicable; theonly modificationmade to the QTUltrasound BreastScanner – 1 is anupdated viewerSoftware Module.
Table 2-2. Testing Performed
Type of Testing	Tests Performed	QT UltrasoundBreast Scanner – 1(K162372)	Modified QTUltrasound BreastScanner – 1(This submission)
Software Verificationand Validation	Software was tested atthe module and systemlevels to ensure that itmet the software'sdesign and intended userequirements. Allrequirements were met,and no new issues ofsafety or effectivenesscompared to thepredicate device wereraised.	Performed	Performed
System Verification andPerformance	System verificationtesting was conducted toensure that the QTUltrasound BreastScanner – 1 met designrequirements. Inaddition, the followingsystem performancecharacteristics arereported:• Measurement Range /Accuracy• Spatial Resolution• Contrast Resolution /Contrast to NoiseRatio• Speed of SoundUniformity andAccuracyAll requirements weremet, and no new issuesof safety oreffectiveness comparedto the predicate device	Performed	Not Applicable; theonly modificationmade to the QTUltrasound BreastScanner – 1 is anupdated QTviewerSoftware Module.
Table 2-2. Testing Performed
Type of Testing	Tests Performed	QT UltrasoundBreast Scanner – 1(K162372)	Modified QTUltrasound BreastScanner – 1(This submission)
BiocompatibilityISO 10993-1:2009/(R)2013 -Biological evaluation ofmedical devices - Part 1:Evaluation and testingwithin a riskmanagement process	Biocompatibility testingwas conducted to ensurethat the patientcontacting materials inthe QT UltrasoundBreast Scanner - 1 metdesign requirements. Allrequirements were met,and no new issues ofsafety or effectivenesscompared to thepredicate device wereraised.	Performed	Not Applicable; theonly modificationmade to the QTUltrasound BreastScanner – 1 is anupdated QTviewerSoftware Module.
ISO 10993-5:2009/(R)2014 -Biological evaluation ofmedical devices - Part 5:Tests for in vitrocytotoxicity
ISO 10993-10:2010/(R)2014 -Biological evaluation ofmedical devices - Part10: Tests for irritationand skin sensitization
ISO 10993-11:2006/(R)2010 -Biological evaluation ofmedical devices - Part11: Tests for systemictoxicity
Cleaning ProceduresScan Tank	Microbial analysis andparticulate testing of thewater in the scan tankwas conducted. Allrequirements were met,and no new issues ofsafety or effectivenesscompared to thepredicate device wereraised.	Performed	Not Applicable; theonly modificationmade to the QTUltrasound BreastScanner – 1 is anupdated QTviewerSoftware Module.

{9}------------------------------------------------

Image /page/9/Picture/0 description: The image shows the logo for "QT ultrasound". The letters "QT" are in a light green color, with the "Q" being larger than the "T". The word "ultrasound" is in a light gray color and is placed to the right of the "QT".

{10}------------------------------------------------

Image /page/10/Picture/0 description: The image shows the logo for "QT ultrasound". The logo is in a light green color. The letters "QT" are larger than the word "ultrasound".

{11}------------------------------------------------

Image /page/11/Picture/0 description: The image contains the text "QT ultrasound". The letters "QT" are larger and in a different color than the word "ultrasound". The text appears to be a logo or branding element.

{12}------------------------------------------------

Image /page/12/Picture/0 description: The image shows the logo for QT Ultrasound. The logo consists of the letters "QT" in a light green color, with the word "ultrasound" in a light gray color next to it. The logo is simple and modern, and it is likely used to represent a medical imaging company.

8.0 SUMMARY OF CLINICAL TESTING

The modified QT Ultrasound Breast Scanner - 1 is a class II device, and has the same equivalent intended use, operating principles, fundamental scientific technology, technological characteristics, physical and operational specifications as predicate, QT Ultrasound Breast Scanner - 1 (K162372); clinical data is not required for substantial equivalence.

9.0 CONCLUSION

The submission device is a modification to the QT Ultrasound Breast Scanner - 1. The modified QT Ultrasound Breast Scanner - 1 is substantially equivalent to the QT Ultrasound Breast Scanner - 1 as previously cleared in K162372, with respect to intended use, principle of operation, design, performance, method of display and safety features. Both devices are intended as an adjunct to mammography and are not intended for screening purposes. The primary difference between modified device and the OT Ultrasound Breast Scanner - 1 (K162372) is the newer version of the QTviewer software.

QT Ultrasound has demonstrated through verification and validation testing that the modifications made to the QTviewer software as part of the QT Ultrasound Breast Scanner - 1 (K162372) do not raise new or different questions of safety and effectiveness. Therefore, it is the opinion of QT Ultrasound LLC that the modified QT Ultrasound Breast Scanner - 1 is substantially equivalent to the predicate device identified in this submission that is currently cleared for market in the United States.

Regulation Number and Section

N/A